OncoLink en espanõl
Share
Types of Cancer > Lung Cancers > Lung Cancer > News
November 2009
Age should not affect chemotherapy choice for stage IV lung cancer: guidelines
Low BMI linked to elevated lung cancer risk in smokers
October 2009
Zoledronic acid may improve survival of lung cancer with bone metastases
September 2009
Hormone therapy may increase lung cancer mortality
August 2009
Chemotherapy for lung cancer enhances quality-adjusted survival
Erlotinib improves survival in stage III non-small cell lung cancer
July 2009
Ovary removal may raise risk of lung cancer
Upregulated microRNA-21 linked to lung cancer in nonsmokers
PET-CT improves preoperative staging of non-small cell lung cancer
June 2009
Nicotinic receptor may be useful target in lung cancer treatment
May 2009
Stereotactic body radiation slows lung cancer
Novel blood biomarker improves accuracy of lung cancer prediction model
Concurrent chemoradiation lengthens lung cancer survival
Lung cancer survival slightly improved with cetuximab use
April 2009
Acrylamide intake not linked to lung cancer in men
Vandetanib has some advantage over gefitinib in non-small-cell lung cancer
Urine test may determine risk for lung cancer in smokers
Stereotactic radiotherapy effective in early inoperable lung cancer
Single clone source seen with multifocal lung cancers
Disparities in lung cancer treatment show no signs of resolving in US
Lung ventilation protocol minimizes injury during lung cancer surgery
March 2009
Long-term use of high-dose carotenoid supplements tied to lung cancer risk
TB associated with long-term risk of lung cancer
Smoking partially responsible for lung cancer link with lower socioeconomic status
January 2009
Outcomes similar for blacks and whites with lung cancer when surgery is advised
December 2008
Quality of life suffers with cranial radiation to prevent lung cancer metastases
BRCA1 haplotype influences lung cancer chemotherapy
November 2008
Oral agent suitable for previously treated non-small-cell lung cancer
CT screening may detect early lung cancer but can lead to unneeded surgery
October 2008
Young patients with lung cancer have better survival than older patients
Gene variants linked to risk for nicotine dependence and lung cancer
CT-guided bronchoscopy doesn't improve lung cancer diagnosis
September 2008
Patients with rheumatoid arthritis at increased risk of lung cancer
Promise dimmed for Toll-like receptor 9 agonist for lung cancer
"Bidi" smoking increases risk of lung cancer substantially
Weekly paclitaxel an option in elderly lung cancer patients
Dietary alpha-tocopherol intake linked with lung cancer risk reductions
August 2008
Initial chemo beneficial in lung cancer brain metastasis
July 2008
Erlotinib continues to show promise in lung cancer
Gene expression profiles with clinical data prognostic for early stage lung cancer
New device provides real-time assessment of lung cancer status
May 2008
Dietary boron and HRT reduce lung cancer risk in women
Alpha1-antitrypsin deficiency carrier status linked to lung cancer
Blood test for early lung cancer shows promise
Maintenance pemetrexed delays lung cancer growth
April 2008
High-intensity chemo does not improve survival in small cell lung cancer
Increased lung cancer risk seen with inhaled insulin
Genetic variant linked to nicotine dependence and lung cancer
March 2008
First-line EGFR inhibition may benefit selected lung cancer patients
Autoantibody assay may lead to earlier detection of lung cancer
DNA methylation markers predict early recurrence of lung cancer
Sunitinib exhibits efficacy in refractory non-small-cell lung cancer
Biomarker profile may allow tailored treatment of non-small cell lung cancer
February 2008
Exhaled breath condensate can contain lung cancer DNA
Recentin fails lung cancer trial
Passive smoking associated with lung cancer risk in Japanese women
EU panel recommends Alimta use for lung cancer
Minimally invasive methods allow near-complete lung cancer staging
January 2008
Surgery for non-small-cell lung cancer improves quality of life
Emphysema detected by low-dose chest CT linked to increased lung cancer risk
Three-gene panel predicts survival in non-small cell lung cancer
December 2007
Serum biomarkers aid lung cancer diagnosis
Isolated knee monoarthritis may indicate non-small-cell lung cancer
Evidence for lung cancer screening deemed overstated
November 2007
Retinoids may reduce lung cancer risk in former smokers
October 2007
Economic return on increased spending for lung cancer minimal
Vandetanib and docetaxel promising against lung cancer
Autoantibodies may identify early stage lung cancer
September 2007
FDG-PET/CT limited in lymph node staging in lung cancer
Knee arthritis may identify early-stage lung cancer
Breath testing may help detect lung cancer
August 2007
Never-smokers with COPD at increased risk of lung cancer-related mortality
Stereotactic single-dose radiotherapy an option for early lung cancer
Roche says EU approves Avastin for lung cancer
Pre-op exercise training safe for patients with lung cancer
Cytokine gene signature points to lung cancer outlook
Prophylactic cranial irradiation reduces brain metastases from extensive lung cancer
Chemo added to radiation improves survival in elderly lung cancer patients
July 2007
Skin rash means erlotinib is working against pancreatic and lung cancer
Stage 1 non-small cell lung cancer benefits from early aggressive treatment
Lung cancer prognosis better for non-smokers than smokers
Colorimetric breath test detects lung cancer
HIV infection linked to increased risk for lung cancer
Erlotinib helps in lung cancer after gefitinib failure
June 2007
Inflammation-related risk factors for lung cancer linked to blood type O
Integrated palliative/oncology care feasible for advanced lung cancer patients
Cisplatin superior to carboplatin for treating curable lung cancer
Preventive brain radiation prolongs survival in advanced lung cancer
May 2007
Molecular imaging tracks lung cancer therapy response
Photodynamic therapy an option in early lung cancer when surgery is not
Prior tumors worsen outlook in lung cancer
EGFR, HER2, P-Akt status has little influence over lung cancer survival
Brain metastases common after successful local treatment of lung cancer
Statins associated with reduced lung cancer risk
Lung cancer risk lower in diabetics taking thiazolidinediones
April 2007
Low-dose CT practical for lung cancer screening
Oncogene implicated in EGFR inhibitor resistance in lung cancer
Autofluorescence bronchoscopy helps detect lung cancer
OLIG1 expression tied to lung cancer prognosis
Erythropoietin gives mixed outcomes in non-small-cell lung cancer-related anemia
Inhaled steroids may stave off lung cancer in COPD patients
March 2007
Sequential chemotherapy helpful in advanced lung cancer
Radiofrequency ablation helpful improves lung cancer survival
CT screening helps catch lung cancer early
Radiotherapy may be preferable to surgery after chemotherapy for lung cancer
Endotoxin exposure may cut risk of lung cancer
CT screening may not improve lung cancer survival
Endoscopic ultrasound tracks lung cancer
February 2007
Age, other factors increase risk of respiratory infections after lung cancer surgery
Colorimetric sensor array uses exhaled breath to ID lung cancer
DNA synthesis and repair genes linked to survival in early lung cancer
High vitamin D levels linked to improved lung cancer survival
Non-smoking-related lung cancer more common in women
Overdiagnosis common in lung cancer screening
Incidentally detected lung cancers less likely to require pneumonectomy
January 2007
Dual tumor suppressors act against lung cancer in mice
Women with non-small-cell lung cancer have better survival than men
Gene signature an independent predictor of lung cancer outcome
Amrubicin shows promise as small-cell lung cancer treatment
December 2006
Nuclear factor-kappaB tied to lung cancer
Cost of protracted palliative therapy justified in late-stage lung cancer
Bevacizumab improves survival of advanced lung cancer
Living near heavy industry linked to increased lung cancer risk in women
November 2006
Incidence of small-cell lung cancer declining in the US
Bortezomib shows some promise against lung cancer
EGFR mutations predict lung cancer response to gefitinib
Radiation plus chemo doubles survival time after lung cancer surgery
October 2006
Annual spiral CT screening detects lung cancer while still curable
U.S. OKs use of Genentech's Avastin in lung cancer
Candidate tumor suppressor could be gene therapy target in lung cancer
Hereditary factors may play role in lung cancer risk
Lung cancer particularly aggressive in patients with HIV
Percutaneous needle biopsy safe in stage I lung cancer
September 2006
Gene variant may raise lung cancer risk from radon exposure
FISH more accurate than cytology for detecting lung cancer
Subset of lung cancer patients benefits from adjuvant cisplatin therapy
August 2006
Chemo completion vital for patients with small-cell lung cancer
Genomic strategy helps predict relapse risk in early lung cancer
Gefitinib effective in patients with EGFR-mutation lung cancer
Survival favorable with resection for primary lung cancer
July 2006
Improved lung cancer survival after thermal ablation plus radiation therapy
Blood test may find early lung cancer: US study
Women smokers more susceptible to lung cancer, but fewer die
Benefits of surgery for non-small cell lung cancer unclear
June 2006
Milk thistle compound inhibits experimental lung cancer growth
Postoperative radiation improves lung cancer survival for some
Cisplatin with irinotecan or etoposide comparable in lung cancer
Sunitinib has promising activity in lung cancer
Celecoxib may increase benefit of erlotinib for lung cancer
May 2006
COPD at lung cancer diagnosis less prevalent in women
Leukemia, lung cancer risk higher in non-Hodgkin's lymphoma survivors
April 2006
Smoking history impacts success of lung cancer therapy
HIV infection tied to elevated lung cancer risk
Airway gene expression signature spots early lung cancer in smokers
March 2006
Thermal ablation plus radiation may extend lung cancer survival
Treatment timing tied to lung cancer survival
Abnormal taste perception can signal SIADH resulting from lung cancer
Chemotherapy sequence affects lung cancer response
Sputum test could help screen for lung cancer
Two mechanisms inactivate lactotransferrin gene in lung cancer
MicroRNA expression profiles aid lung cancer diagnosis and prognosis
CRP level may help predict lung cancer risk in smokers
February 2006
Gemcitabine adds benefit to lung cancer chemotherapy
CT screening identifies curable lung cancers
EGFR overexpression not tied to lung cancer survival
ADAM28 linked to lung cancer growth and spread
January 2006
Hormone replacement therapy may increase lung cancer risk
Among smokers, blacks more susceptible to lung cancer than whites
Palliative radiation may cure lung cancer in very small minority of cases
Value of low-dose CT for lung cancer screening still uncertain
Blacks less likely than whites to undergo surgery for lung cancer
Susceptibility to lung cancer and COPD may be genetically linked
December 2005
Chest x-rays effective in detecting early lung cancer
NSAIDs unlikely to protect against lung cancer
Tumor staging for lung cancer may need revision
Radiofrequency ablation promising against lung cancer
Clinical signs may aid in selection of patients for lung cancer testing
November 2005
Plant product deguelin shows promise in preventing lung cancer
Novel biomarkers indicate likely response to chemotherapy for lung cancer
CO2 laser clears obstructed airway in lung cancer patient
Survival rates in lung cancer higher in women than men
October 2005
DNA changes in buccal mucosa linked to risk of lung cancer
Brachytherapy may change outlook for inoperable lung cancer
Vascular disrupting agent shows promise in early Phase ll lung cancer trial
Eczema patients have a lowered risk of lung cancer
Concurrent/consolidation regimen provides best survival for stage III lung cancer
Weak link between alcohol consumption and lung cancer
September 2005
Smoking reduction, dietary phytoestrogens may reduce lung cancer risk
Tarceva approved in EU for lung cancer
Telomerase inhibitor prevents lung cancer metastases in mice
Neutropenia predicts efficacy of lung cancer chemotherapy
August 2005
Lonafarnib active in taxane-resistant lung cancer
Ultrasound-guided FNA plus mediastinoscopy may improve lung cancer staging
Indoor air pollution heightens lung cancer risk
EGFR mutations do not predict lung cancer response to cetuximab
July 2005
Age no bar to benefits of lung cancer chemotherapy
Erlotinib improves survival in treatment-refractory lung cancer
AstraZeneca releases phase II data on Zactima lung cancer drug
June 2005
Adjuvant chemotherapy improves survival of resected early lung cancer
Family risk factor for lung cancer stronger in blacks
CT and PET screening useful in detecting early lung cancer
High incidence of recurrence in CNS seen in Iressa-responsive lung cancers
Breath analysis detects lung cancer
May 2005
Hispanics fare worse than whites after stage I non-small cell lung cancer diagnosis
Diet may modify risk of radon-related lung cancer
Avastin slows lung cancer progression
Small-cell lung cancer outcome not improved by dose-dense chemo
Wood dust linked to increased lung cancer risk
EGFR gene copy number predicts lung cancer response to gefitinib
April 2005
High-risk individuals should consider testing for lung cancer
Advanced age no bar to combined-modality lung cancer therapy
Exercise test predicts outcome of lung cancer surgery
Two gemcitabine schedules similar for impaired lung cancer patients
Symptoms emerge long before lung cancer diagnosis for many
Brain metastases common in lung cancer patients
March 2005
Ligand says lung cancer drug fails in studies
Routine CT screening may not reduce mortality from lung cancer
Avastin added to chemotherapy prolongs survival in advanced lung cancer
Transesophageal echocardiography identifies aortic invasion by lung cancer
EGFR mutations involved in lung cancer pathogenesis
February 2005
Mutation in EGFR gene makes lung cancers resistant to gefitinib
Fatigue, related to stress, worsens physical function in lung cancer patients
January 2005
KRAS mutations in lung cancer predict poor response to kinase inhibitors
December 2004
Genetics and arsenic raise risk of lung cancer
Good results reported for lung cancer vaccine
Favorable lung cancer trials results reported by Rita Medical
November 2004
Higher conformal radiation dose improves lung cancer control
Diagnostic work-up of CT-detected lung cancer variable
FDA clears Genentech's Tarceva for lung cancer
Hypofractionated proton beam radiotherapy safe, beneficial for stage I lung cancer
Circulating DNA levels predict non-small-cell lung cancer outcomes
Scientists find lung cancer protection gene
Vaccine promising in subset of lung cancer patients
October 2004
EU funds lung cancer vaccine research
Cisplatin v. carboplatin for lung cancer?
Lung cancer chemotherapy no curb on life quality
Two genes distinguish lung cancer from normal tissue
Video-guided lobectomy effective as open surgery against lung cancer
September 2004
ERBB2 kinase mutation offers target in some lung cancers
Smaller stage I non-small cell lung cancers more curable than larger tumors
Peroxiredoxins tied to lung cancer progression
August 2004
EGFR gene mutations common in lung cancers of nonsmokers
Eli Lilly's Alimta approved to treat lung cancer
Lung cancer in nonsmokers seen as distinct disease entity
Resection warranted in transplant recipients with early stage lung cancer
Activated signaling pathway predicts gefitinib response in lung cancer
Allogeneic vaccine shows promise in lung cancer
July 2004
Findings shed light on how gefitinib fights lung cancer
Gene expression profile of biopsy tissue can predict lung cancer outcome
June 2004
NSAIDs reduce lung cancer growth, cachexia in mice
Lung cancer risk similar in men and women with same smoking histories
May 2004
Use of fused PET/CT images may improve radiation targeting for lung cancer
Skip metastases point to improved outcome in lung cancer
Radiolabeled PET scan helpful in lung cancer staging
April 2004
EGFR mutations make lung cancer sensitive to gefitinib
Tarceva drug extends life in lung cancer patients
March 2004
Tobacco-induced rise in CYP1B1 may explain female susceptibility to lung cancer
Low-dose CT detects very few early lung cancer cases
February 2004
Parathyroid protein prompts lung cancer metastasis to bone
January 2004
Small survival benefit seen with chemotherapy after resection of lung cancer
Aventis says drug helps fight advanced lung cancer
Symptom severity influences treatment delays in lung cancer patients
Breast cancer drug Herceptin fails in lung cancer trial
December 2003
Older patients with lung cancer benefit from comprehensive anticancer treatments
Sputum cytometry could improve CT screening for lung cancer
PET more accurate than CT for mediastinal staging in lung cancer
Passive smoke exposure can increase lung cancer risk by nearly one third
Most lung cancers identified by annual low-dose CT screening are stage I lesions
November 2003
PCR test for circulating DNA may allow early lung cancer detection
Targeted high-dose radiotherapy benefits inoperable lung cancer patients
October 2003
Polymorphism in DNA repair gene raises lung cancer risk in heavy smokers
Delay in diagnosing lung cancer does not affect outcome
Benefits of surgery for metastatic lung cancer questioned
Tumor suppressor gene often methylated in smokers with lung cancer
Adjuvant chemotherapy no help after lung cancer surgery
Beliefs of lung cancer patients may compromise treatment
Lung cancer drug trial results disappointing
September 2003
GSTP1 polymorphism increases risk of lung cancer associated with smoking
Aggressive combination therapy effective in elderly lung cancer patients
Routine x-rays, sputum cytology not warranted for lung cancer screening
Low-dose CT scanning cost effective in lung cancer screening
August 2003
Age no bar to carboplatin and paclitaxel lung cancer therapy
Lung cancer trials deemed cost effective
Lung cancer detected early with low-dose CT and selective PET
Initial Taxotere-containing chemotherapy improves survival in lung cancer
Factors other than size predict outcome of totally resected small lung cancers
Proteomic analysis classifies lung cancer and predicts outcome
Paclitaxel-based regimen outperforms standard therapy for small-cell lung cancer
PET imaging predicts response to chemotherapy for non-small cell lung cancer
July 2003
First-line docetaxel improves survival in advanced non-small cell lung cancer
Celecoxib may enhance response to preoperative chemotherapy for lung cancer
Gefitinib effective in advanced, pretreated non-small-cell lung cancer
June 2003
Integrated PET-CT better than either alone at staging non-small-cell lung cancer
Survival improved with adjuvant chemotherapy in resected early lung cancer
May 2003
R115777 shows minimal activity against advanced non-small cell lung cancer
Electronic device can detect scent of lung cancer
FDA approves AstraZeneca's Iressa for non-small cell lung cancer
CYP1A1 gene mutation increases the risk of lung cancer
April 2003
NSAID use may protect smokers against lung cancer
Postoperative adjuvant bestatin prolongs survival in stage I squamous cell lung cancer
Number of lymph nodes examined impacts survival in early NSC lung cancer
March 2003
UK survey shows elderly lung cancer patients get poor quality care
Pros and cons of widespread CT lung cancer screening still debated
February 2003
CT scan detects early lung cancer
Plant product shows promise as anti-lung cancer agent
Irradiated, GM-CSF-secreting tumor cells can engender lung cancer immunity
Incidence of HIV-related lung cancer up in the era of HAART
Retinoid therapy may help prevent lung cancer in ex-smokers
January 2003
Large new thalidomide trial goes ahead in lung cancer
Heavy-ion radiotherapy feasible for inoperable lung cancer
Economics, safety consequences outweigh benefit of lung cancer screening with helical CT
December 2002
Lung cancer deaths drop in women in UK
Oral paclitaxel with cyclosporine active against non-small-cell lung cancer
November 2002
Gene may help predict survival in non small-cell lung cancer patients
Demographic model useful for prediction of lung cancer risk
October 2002
Outcomes do not justify use of intensified chemotherapy in small-cell lung cancer
High false-positive rate seen with CT scans for lung cancer
Cisplatin somewhat better than carboplatin as treatment for advanced lung cancer
Waist circumference may predict type of lung cancer in women
Diesel pollution in US said to raise lung cancer risk substantially
September 2002
Paclitaxel plus gemcitabine provides alternative lung cancer regimen
Early detection of lung cancers possible using breath test
Lung cancer risk in nonsmoking women increases with environmental exposure
New radiotherapy regimen improves lung cancer survival
August 2002
Addition of Iressa to standard therapy does not improve lung cancer survival
Early radiation advised for limited-stage small-cell lung cancer
Spiral CT promising for lung cancer screening
July 2002
Carboplatin, docetaxel and irinotecan improves lung cancer outcome
Lung cancer chemotherapy resistance linked to systemic DNA repair capacity
Gene-expression profiles in stage I lung cancer predict survival
Polymorphisms of surfactant gene may increase lung cancer susceptibility
Paclitaxel/carboplatin regimens have improved lung cancer survival
June 2002
Second-hand smoke causes lung cancer: international experts
Move to vented stoves reduces lung cancer rate in China
May 2002
Leanness not directly related to lung cancer mortality
Oral enzyme blocker may slow advanced lung cancer
Nicotine suppresses antigrowth effects of retinoids in lung cancer cells
April 2002
Lung cancer linked with polymorphisms common among African Americans
PET scan can prevent unnecessary lung cancer surgery
Drug failure in small-cell lung cancer elucidated
March 2002
Race, sex, socioeconomic status affect chemotherapy referral for lung cancer
p53 appears to inhibit angiogenesis in non-small-cell lung cancer
Long-term air pollution exposure tied to lung cancer, cardiopulmonary mortality
February 2002
Newer lung cancer chemotherapy significantly more costly than older regimen
Social factors may explain racial disparity in lung cancer survival
Adenosine triphosphate improves nutritional status in lung cancer patients
Immunochemical assays may help predict survival after lung cancer resection
Treatment history predicts lung cancer risk in patients with Hodgkin's disease
Age should not be a barrier to cisplatin-based therapy for lung cancer
Diet, reproductive factors may protect against lung cancer
January 2002
Gene variant linked with lower risk of lung cancer
Metabolic differences may explain low lung cancer rate in Chinese-Americans
Findings clarify effectiveness of current lung cancer treatment regimens
December 2001
Gene expression patterns distinguish subtypes of non-small cell lung cancer
Cervical and lung cancers are frequent and aggressive in women with HIV
Smoking cessation can markedly reduce small-cell lung cancer risk
Gene loss may cause first abnormalities leading to lung cancer
November 2001
Incidence of lung cancer may be increasing in non-smoking European men
Surgical selection criteria for lung cancer patients with emphysema may need revision
Limited resection often preferable to lobectomy for elderly lung cancer patients
Donor-derived small cell lung cancer reported in kidney transplant recipient
Researchers baffled as breast overtakes lung cancer in UK
October 2001
Novel regimen may extend survival in HER-2/neu+ NSC lung cancer
September 2001
Postoperative radiotherapy warranted in some non-small-cell lung cancer patients
Lung cancer set to be women's top cancer killer
Lung cancer invasion-suppressor gene identified
August 2001
Pleural lymphocytes may aid prognosis in non-small cell lung cancer
Cryotherapy might be first-line treatment for early lung cancer
Celecoxib studied as lung cancer preventative
July 2001
Paclitaxel and carboplatin offer less toxic treatment option for lung cancer
Annual CT screening of high-risk subjects permits earlier lung cancer diagnosis
Imaging agent enhances diagnosis of lung cancer metastasis
May 2001
Tumor cell vaccine safe for patients with non-small-cell lung cancer
In lung cancer patients, not all markers of bone metastases equally useful
Sushi may protect Japanese against rare type of lung cancer
April 2001
Isotretinoin does not prevent secondary tumors in NSC lung cancer patients
PCR assay sensitively detects lung cancer cells in blood and sputum
Investigational lung cancer drug fails phase lll trial
Tumor suppressor p53 overexpressed in exfoliated lung cancer cells
Fluorescence bronchoscopy detects non-small cell lung cancer recurrence
March 2001
Declining lung cancer mortality linked to reduced-tar cigarettes
February 2001
LUNX gene preferentially expressed by non-small-cell lung cancer
January 2001
Resection of isolated adrenal metastases improves lung cancer survival
November 2000
Serum telomerase levels may be useful in lung cancer screening
DNA repair capacity linked with increased lung cancer risk
October 2000
Concurrent chemoradiation improves survival in some lung cancers
Survival unaffected by chemotherapy after non-small-cell lung cancer resection
Photodynamic therapy effective in early non-small-cell lung cancer
Bioavailable lycopene protects against lung cancer in smokers and nonsmokers
Physiologic, not genetic, factors dominate in p53-associated lung cancer
September 2000
More evidence supports genetic predisposition to lung cancer
Low-dose chemotherapy schedule effective in advanced lung cancer
Age not a contraindication for lung cancer chemotherapy
AstraZeneca lung cancer product shows early promise
Depression underestimated in lung cancer patients
Depression can occur after successful lung cancer treatment
August 2000
Screening does not reduce long-term lung cancer mortality
Smokers who quit in middle age greatly reduce their risk of lung cancer
July 2000
PET better than CT at staging lung cancer, detecting metastasis
Cell Pathways, Glaxo Wellcome to conduct non-small cell lung cancer study
June 2000
Surgical outcome of sulcus lung cancer provides a benchmark for new therapies
CT alone can evaluate lymph nodes in subset of patients with NSC lung cancer
Alcohol may enhance smoking-related p53 mutations in lung cancer
Early detection of non-small-cell lung cancer tumors does not improve survival
Incyte, Roy Castle International Centre to research lung cancer genetics
Exposure to residential radon a "significant" cause of lung cancer in women
Lung cancer responds to experimental drug
May 2000
Elimination of COX-2 gene inhibits growth of lung cancer tumors in mice
Anti-VEGF drug delays recurrence of metastatic lung cancer
Docetaxel after chemoradiotherapy prolongs survival in non-small-cell lung cancer
Elderly lung cancer patients in UK are undertreated
Asian immigrants have poor lung cancer prognosis
Lung cancer detected earlier with CT scan than with X-ray
April 2000
Novelos Therapeutics begins enrollment for phase I/II lung cancer trial
March 2000
Induction chemotherapy before surgery effective for non small-cell lung cancer
Decitabine shows promise in treatment of non-small-cell lung cancer
February 2000
Revised lung cancer staging system accurately reflects prognosis
Nonsmokers' exposure to tobacco smoke in public places increases lung cancer risk
Air pollutants may slightly increase lung cancer risk
Preliminary lung cancer vaccine data show encouraging survival trend
January 2000
Gene expression may explain why women's lung cancer risk is higher than men's
December 1999
Long-term lung cancer survival more likely in women than in men
Proton radiotherapy safe and effective for non-small-cell lung cancer
Computed tomography screening detects very early stage lung cancer
November 1999
Telomerase activity has prognostic significance in non-small-cell lung cancer
October 1999
Gemcitabine plus vinorelbine moderately active in elderly non-small-cell lung cancer cases
Aerosol agents for very early lung cancer show promise
Hydrazine exposure increases risk of lung cancer mortality among aerospace workers
September 1999
Physical activity inversely correlated with lung cancer in men
July 1999
NeoPath, Bayer to develop automated lung cancer test
June 1999
Reduced follow-up safe for patients with resected non-small-cell lung cancer
Corixa to research lung cancer vaccine with Japan Tobacco
Regional shifts in lung cancer mortality over time linked to smoking trends
Risk of lung cancer, COPD elevated in some porphyrias
May 1999
Second-line therapy with docetaxel prolongs survival in non-small-cell lung cancer patients
April 1999
Annual worldwide incidence highest for lung cancer compared with other cancers
March 1999
Non-small cell lung cancer lesions missed on chest radiograph in 19% of cases
February 1999
Use of beer, spirits increases lung cancer risk; use of moderate amounts of wine protective
Same oncogenes found in lungs and bronchoalveolar lavage fluid of lung cancer patients
Lilly's MTA promising treatment for head and neck cancer, NSC lung cancer
January 1999
IGF-I, IGF binding protein-3 may affect lung cancer risk